Although CD133 and CD24 are putative markers for cancer stem cells in human brain and colon cancers, respectively, the present results do not indicate that the residual cells are cancer stem cells because cancer stem cells in human lung cancer have not yet been identified. The gene discussed is PROM1; the disease is lung carcinoma.